Breast Cancer Update Podcast Por Dr. Neil Love arte de portada

Breast Cancer Update

Breast Cancer Update

De: Dr. Neil Love
Escúchala gratis

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.Copyright 2025 Research To Practice. All Rights Reserved Ciencia Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

    Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
    Mar 2 2026

    Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Sara M Tolaney from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data with antibody-drug conjugates in the management of breast cancer.

    CME information and select publications here.
    Más Menos
    59 m
  • Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

    Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series
    Jan 27 2026

    Dr Angela DeMichele from the Abramson Cancer Center in Philadelphia, Pennsylvania, Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Seth Wander from Massachusetts General Hospital in Boston discuss real-world cases and recent clinical data surrounding the management of HR-positive breast cancer.

    CME information and select publications here.
    Más Menos
    2 h y 1 m
  • HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

    HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series
    Jan 14 2026

    Prof Giuseppe Curigliano from the University of Milan in Italy, Prof Nadia Harbeck from LMU University Hospital in Munich, Germany, Dr Ian E Krop from Yale Cancer Center, Dr Nancy U Lin from Dana-Farber Cancer Institute and Dr Joyce O’Shaughnessy from Baylor University Medical Center discuss real-world cases and recent clinical data pertinent to the management of HER2-positive breast cancer.

    CME information and select publications here.

    Más Menos
    1 h y 58 m
Todavía no hay opiniones